# Prenatal valproate exposure alters midbrain and striatal neuronal morphology along with dopamine levels

**Authors:** Barbora Bugar Bodorova, Tomas Havranek, Denisa Mihalj, Kristina Kupkova, Ema Bogyova, Hisham El Falougy, Zuzana Bacova, Jan Bakos

PMC · DOI: 10.1007/s00429-026-03090-z · Brain Structure & Function · 2026-03-02

## TL;DR

Prenatal exposure to valproate changes brain neuron structure and dopamine levels in ways linked to autism-like symptoms.

## Contribution

This study reveals region-specific neuronal and dopaminergic changes in midbrain and striatum due to prenatal valproate exposure.

## Key findings

- VTA neurons from VPA-exposed rats had fewer and shorter neurites.
- Midbrain dopamine levels were significantly higher in VPA-exposed rats.
- Dopamine receptor type 4 gene expression increased in the VTA of male VPA-exposed rats.

## Abstract

Alterations in dopaminergic pathways are implicated in the pathogenesis of neuropsychiatric disorders, including autism spectrum disorder (ASD). However, changes in morphology and neurite outgrowth within the dopaminergic system under autism-relevant conditions remain poorly understood. Prenatal valproate (VPA) administration is a well-established animal model for studying autism-related brain changes in offspring. Therefore, the aim of this study was to examine the effects of prenatal VPA exposure on (1) the morphology of primary neurons isolated from dopaminergic brain regions, and (2) the expression of molecular motors and neurite outgrowth-related proteins, along with (3) the levels of dopamine and dopamine receptors in the midbrain and striatum, analysed at postnatal day 30 (P30). Neurons from the ventral tegmental area (VTA) of rats prenatally exposed to VPA showed a significant reduction in both the number and length of neurites. Similar, but to a lesser extent, changes were also found in primary striatal tyrosine hydroxylase (TH)-positive neurons, compared to controls. A significant increase in total dopamine levels was observed in the midbrain of rats prenatally exposed to VPA, regardless of sex, while no significant changes were detected in the striatum at P30. TH levels were unchanged in dopaminergic regions at P30, while dopamine receptor type 4 gene expression was significantly increased in the VTA of prenatally VPA-exposed male rats, with no other significant gene expression changes. These results demonstrate that prenatal VPA exposure induces region-specific neuronal and dopaminergic changes in the midbrain and striatum, enhancing our understanding of the neurodevelopmental mechanisms potentially underlying ASD-like symptomatology.

The online version contains supplementary material available at 10.1007/s00429-026-03090-z.

## Linked entities

- **Chemicals:** valproate (PubChem CID 3549980), dopamine (PubChem CID 681)
- **Diseases:** autism spectrum disorder (MONDO:0005258)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Wnt2 (Wnt family member 2) [NCBI Gene 114487] {aka Wnt}, Dr1 (down-regulator of transcription 1) [NCBI Gene 289881], Map2 (microtubule-associated protein 2) [NCBI Gene 17756] {aka G1-397-34, MAP-2, Mtap-2, Mtap2, repro4}, Map2 (microtubule-associated protein 2) [NCBI Gene 25595] {aka MAP2R, Mtap2}, Th (tyrosine hydroxylase) [NCBI Gene 25085] {aka The}, Wnt5a (Wnt family member 5A) [NCBI Gene 64566], Glyceraldehyde 3-phosphate dehydrogenase [NCBI Gene 108351137], HLA-DRB4 (major histocompatibility complex, class II, DR beta 4) [NCBI Gene 3126] {aka DR4, DRB4, HLA-DR4B, HLA-DRB, HLA-DRB4*}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 24383] {aka BARS-38, Gapd}, Th (tyrosine hydroxylase) [NCBI Gene 21823]
- **Diseases:** dopaminergic dysfunction (MESH:D009422), Angelman syndrome (MESH:D017204), social dysfunction (MESH:D000067404), ASD (MESH:D000067877), autism (MESH:D001321), neuropsychiatric disorders (MESH:D001523)
- **Chemicals:** paraformaldehyde (MESH:C003043), chloroform (MESH:D002725), l-glutamine (MESH:D005973), CO2 (MESH:D002245), 4',6-diamidino-2-phenylindole (MESH:C007293), Tween (MESH:D011136), Dopamine (MESH:D004298), polyvinylidene difluoride (MESH:C024865), Hepes (MESH:D006531), penicillin (MESH:D010406), glycerol (MESH:D005990), A21428 (-), VPA (MESH:D014635), Alexa Fluor 488 (MESH:C000711379), TRIzol (MESH:C411644), water (MESH:D014867), phenol (MESH:D019800), Immobilon (MESH:C004820), GABA (MESH:D005680), HCl (MESH:D006851), SDS (MESH:D012967), Alexa Fluor 555 (MESH:C000608607), Saline (MESH:D012965), Triton X-100 (MESH:D017830), streptomycin (MESH:D013307), bromophenol blue (MESH:D001978)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12953354/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12953354/full.md

---
Source: https://tomesphere.com/paper/PMC12953354